GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chong Kun Dang Holdings Corp (XKRX:001630) » Definitions » Capital Expenditure

Chong Kun Dang Holdings (XKRX:001630) Capital Expenditure : ₩-44,644.29 Mil (TTM As of Sep. 2024)


View and export this data going back to 1976. Start your Free Trial

What is Chong Kun Dang Holdings Capital Expenditure?

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Chong Kun Dang Holdings's cash flow for capital expenditures for the three months ended in Sep. 2024 was ₩-26,622 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Sep. 2024 was ₩-44,644.29 Mil.

Chong Kun Dang Holdings Capital Expenditure Historical Data

The historical data trend for Chong Kun Dang Holdings's Capital Expenditure can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Chong Kun Dang Holdings Capital Expenditure Chart

Chong Kun Dang Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capital Expenditure
Get a 7-Day Free Trial Premium Member Only Premium Member Only -129,851.60 -117,952.86 -103,138.29 -65,270.18 -32,076.40

Chong Kun Dang Holdings Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Capital Expenditure Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7,842.24 -5,848.07 -5,393.64 -6,780.44 -26,622.15

Chong Kun Dang Holdings Capital Expenditure Calculation

Cash flow for capital expenditures refers to the funds spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Capital Expenditure for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-44,644.29 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Chong Kun Dang Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Chong Kun Dang Holdings Corp (XKRX:001630) » Definitions » Capital Expenditure
Comparable Companies
XKRX:007570 XKRX:084110 XKRX:096760 XKRX:293480 XKRX:102460 XKRX:000020 XKRX:003060 XKRX:092040 XKRX:271980 XKRX:256840 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
368, 3-ga, Choongjungro, Suhdaemoon-gu, Seoul, KOR, 120-756
Website
http://www.ckdpharm.com
Chong Kun Dang Holdings Corp manufactures and markets medicines and active pharmaceutical ingredients. It offers prescription drugs; over-the-counter pharmaceutical products; health supplements and consumer health products. Geographically activities are functioned through the region of South Korea.

Chong Kun Dang Holdings Headlines

No Headlines